Possibilities of modern 1-adreno blockers in the treatment of patients with benefit of prostate hypertension

When selecting the optimal drug therapy for patients with prostatic hyperplasia, an individual approach is required, which consists in determining the severity and nature of urination disorders, taking into account risk factors for the progression of BPH, diagnosing such concomitant conditions as bladder hyperactivity and erectile dysfunction. The patient's preferences and expectations are of great importance.